Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,330
Total Claims
$728K
Drug Cost
329
Beneficiaries
$2,212
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-80%
Opioid rate vs peers
0.4% vs 2.2% avg
+57%
Cost per patient vs peers
$2,212 vs $1,411 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.4%
Opioid Rate
41
Opioid Claims
$335
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 976 claims · $574K
Generic: 8,217 claims · $147K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 81 | $113K |
| Apixaban | 58 | $92K |
| Insulin Glargine,hum.Rec.Anlog | 67 | $52K |
| Dapaglifloz Propaned/Metformin | 39 | $51K |
| Rivaroxaban | 19 | $29K |
| Insulin Nph Hum/Reg Insulin Hm | 52 | $26K |
| Empagliflozin | 17 | $20K |
| Levothyroxine Sodium | 131 | $16K |
| Insulin Lispro | 21 | $15K |
| Sitagliptin Phos/Metformin Hcl | 15 | $15K |
| Insulin Lispro Protamin/Lispro | 26 | $14K |
| Insulin Nph Hum/Reg Insulin Hm | 19 | $11K |
| Budesonide/Formoterol Fumarate | 26 | $9,488 |
| Metoprolol Succinate | 356 | $8,162 |
| Losartan Potassium | 358 | $7,381 |
Prescribing Profile
Patient Profile
76
Avg Age
59%
Female
2.42
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About